Cargando…

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype

Since the discovery of severe alpha-1 antitrypsin deficiency as a genetic risk factor for emphysema, there has been ongoing debate over whether individuals with intermediate deficiency with one protease inhibitor Z allele (PiMZ, or MZ) are at some risk for emphysema. This is important, because MZ in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Ashry, Haitham S., Strange, Charlie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488576/ https://www.ncbi.nlm.nih.gov/pubmed/29070580 http://dx.doi.org/10.1183/16000617.0068-2017

Ejemplares similares

Low Serum Alpha-1 Antitrypsin (AAT) in Family Members of Individuals with Autism Correlates with PiMZ Genotype
por: Russo, Anthony J., et al.
Publicado: (2009)

Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide
por: Martinez-González, Cristina, et al.
Publicado: (2021)

Why do some adults with PiMZ α(1)-antitrypsin develop bronchiectasis?
por: Aggarwal, Nupur, et al.
Publicado: (2016)

Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations
por: Foil, Kimberly E., et al.
Publicado: (2018)

Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype
por: Chen, Vincent L., et al.
Publicado: (2022)

Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis
por: Barjaktarevic, Igor, et al.
Publicado: (2021)

Is PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?
por: McGee, Dawn, et al.
Publicado: (2010)

Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk
por: Rabekova, Zuzana, et al.
Publicado: (2021)

Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency
por: Sandhaus, Robert A, et al.
Publicado: (2020)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
por: Beiko, Tatsiana, et al.
Publicado: (2019)

Clinical considerations in individuals with α(1)-antitrypsin PI*SZ genotype
por: McElvaney, Gerard N., et al.
Publicado: (2020)

Prevalence of α(1)-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review
por: Blanco, Ignacio, et al.
Publicado: (2020)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
por: Brantly, Mark, et al.
Publicado: (2020)

“Why do some adults with PiMZ α(1)-antitrypsin develop bronchiectasis?” Nupur Aggarwal, Beatriz Martinez Delgado, Sandeep Salipalli, Nerea Matamala, Jessica Rademacher, Nicolaus Schwerk, Tobias Welte, Sabina Janciauskiene and Felix C. Ringshausen. ERJ Open Res 2016; 2: 00021-2016.
Publicado: (2016)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
por: Rahaghi, Franck F, et al.
Publicado: (2020)

Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update
por: Blanco, Ignacio, et al.
Publicado: (2017)

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide
por: Blanco, Ignacio, et al.
Publicado: (2017)

Clathrin-mediated Endocytosis of Alpha-1 Antitrypsin is Essential for its Protective Function in Islet Cell Survival
por: Wang, Jingjing, et al.
Publicado: (2019)

Alpha-1 antitrypsin genotypes in breast cancer patients
por: El-Akawi, Z, et al.
Publicado: (2005)

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
por: Zhumagaliyeva, Ardak, et al.
Publicado: (2017)

Proteomic Analysis of Exosomes Secreted from Human Alpha-1 Antitrypsin Overexpressing Mesenchymal Stromal Cells
por: Wei, Hua, et al.
Publicado: (2021)

Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
por: Tanash, Hanan A, et al.
Publicado: (2010)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Prevalence of PI*Z and PI*S alleles of alpha-1-antitrypsin deficiency in Finland
por: Häggblom, Jan, et al.
Publicado: (2015)

Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis
por: Al-Jameil, Noura, et al.
Publicado: (2017)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Targeted screening programmes in COPD: how to identify individuals with α(1)-antitrypsin deficiency
por: Chorostowska-Wynimko, Joanna
Publicado: (2015)

Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
por: Denden, Sabri, et al.
Publicado: (2010)

Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?
por: Godoy, Irma
Publicado: (2016)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
por: Russo, Rodrigo, et al.
Publicado: (2016)

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States
por: Sieluk, Jan, et al.
Publicado: (2020)

Immortalized Mesenchymal Stromal Cells Overexpressing Alpha-1 Antitrypsin Protect Acinar Cells from Apoptotic and Ferroptotic Cell Death
por: Shoeibi, Sara, et al.
Publicado: (2023)

Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study
por: Stocks, James M, et al.
Publicado: (2010)

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
por: Nakanishi, Tomoko, et al.
Publicado: (2020)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Clinical manifestations in patients with PI*MM(Malton) genotypes. A matter still unsolved in alpha‐1 antitrypsin deficiency
por: Aiello, Marina, et al.
Publicado: (2020)

Overexpression of alpha‐1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice
por: Song, Lili, et al.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uja90riuogetvaicimk439dl9b